KFDA to introduce Good Review Practice

Published: 2004-05-27 06:57:00

Updated: 2004-05-27 06:57:00

The Korea Food and Drug Administration unveiled its plan to introduce a new good review practice (GRP) system as part of its efforts to ensure transparency, consistence and specialty in screening drug-related applications, adding that such introduction will contribute to pharmaceutical exports in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK